These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33011303)

  • 41. [Antileukotrienes and Churg-Strauss syndrome].
    Guilpain P; Pagnoux C; Lhote F; Mouthon L; Guillevin L
    Presse Med; 2007 May; 36(5 Pt 2):890-4. PubMed ID: 17383148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies targeting the interleukin-5 signaling pathway used as add-on therapy for patients with severe eosinophilic asthma: a review of the mechanism of action, efficacy, and safety of the subcutaneously administered agents, mepolizumab and benralizumab.
    Hillas G; Fouka E; Papaioannou AI
    Expert Rev Respir Med; 2020 Apr; 14(4):353-365. PubMed ID: 31958239
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical Development of Mepolizumab for the Treatment of Severe Eosinophilic Asthma: On the Path to Personalized Medicine.
    Pavord ID; Menzies-Gow A; Buhl R; Chanez P; Dransfield M; Lugogo N; Keene ON; Bradford ES; Yancey SW
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1121-1132.e7. PubMed ID: 32889223
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Zafirlukast and Churg-Strauss syndrome.
    Wechsler ME; Drazen JM
    Chest; 1999 Jul; 116(1):266-7. PubMed ID: 10424543
    [No Abstract]   [Full Text] [Related]  

  • 45. Zafirlukast and Churg-Strauss syndrome.
    Katz RS; Papernik M
    JAMA; 1998 Jun; 279(24):1949; author reply 1950. PubMed ID: 9643848
    [No Abstract]   [Full Text] [Related]  

  • 46. Churg-Strauss syndrome.
    Wechsler M; Drazen JM
    Lancet; 1999 Jun; 353(9168):1970-1. PubMed ID: 10371594
    [No Abstract]   [Full Text] [Related]  

  • 47. Mepolizumab: 240563, anti-IL-5 monoclonal antibody - GlaxoSmithKline, anti-interleukin-5 monoclonal antibody - GlaxoSmithKline, SB 240563.
    Drugs R D; 2008; 9(2):125-30. PubMed ID: 18298130
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Churg-Strauss syndrome associated with montelukast].
    Ozlen B; Ozdemir L; Eskitütüncü B; Cevirme L; Kurtar N; Soy M; Hatipoğlu ON
    Tuberk Toraks; 2008; 56(4):434-8. PubMed ID: 19123080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma.
    García-Mochón L; Gil-Sierra MD; Alegre-Del Rey EJ; Alarcón de la Lastra-Romero C; Sánchez-Hidalgo M
    Farm Hosp; 2019 Nov; 43(6):187-193. PubMed ID: 31705642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-IL-5 in Mild Asthma Alters Rhinovirus-induced Macrophage, B-Cell, and Neutrophil Responses (MATERIAL). A Placebo-controlled, Double-Blind Study.
    Sabogal Piñeros YS; Bal SM; van de Pol MA; Dierdorp BS; Dekker T; Dijkhuis A; Brinkman P; van der Sluijs KF; Zwinderman AH; Majoor CJ; Bonta PI; Ravanetti L; Sterk PJ; Lutter R
    Am J Respir Crit Care Med; 2019 Feb; 199(4):508-517. PubMed ID: 30192638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen Patients.
    Jachiet M; Samson M; Cottin V; Kahn JE; Le Guenno G; Bonniaud P; Devilliers H; Bouillet L; Gondouin A; Makhlouf F; Meaux-Ruault N; Gil H; Bienvenu B; Coste A; Groh M; Giraud V; Dominique S; Godeau B; Puéchal X; Khouatra C; Ruivard M; Le Jeunne C; Mouthon L; Guillevin L; Terrier B;
    Arthritis Rheumatol; 2016 Sep; 68(9):2274-82. PubMed ID: 26946346
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute Churg-Strauss syndrome in an asthmatic patient receiving montelukast therapy.
    Tang MB; Yosipovitch G
    Arch Dermatol; 2003 Jun; 139(6):715-8. PubMed ID: 12810501
    [No Abstract]   [Full Text] [Related]  

  • 54. Mepolizumab: A Review in Eosinophilic Asthma.
    Deeks ED
    BioDrugs; 2016 Aug; 30(4):361-70. PubMed ID: 27311938
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood Eosinophil Depletion with Mepolizumab, Benralizumab, and Prednisolone in Eosinophilic Asthma.
    Moran AM; Ramakrishnan S; Borg CA; Connolly CM; Couillard S; Mwasuku CM; Pavord ID; Hinks TSC; Lehtimӓki L
    Am J Respir Crit Care Med; 2020 Nov; 202(9):1314-1316. PubMed ID: 32584603
    [No Abstract]   [Full Text] [Related]  

  • 56. Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use.
    Albers FC; Hozawa S; Bratton DJ; Yancey SW; Prazma CM; Humbert M; Liu MC
    Allergy; 2020 Apr; 75(4):942-946. PubMed ID: 31520471
    [No Abstract]   [Full Text] [Related]  

  • 57. Mepolizumab in adolescents with severe eosinophilic asthma not eligible for omalizumab: one center's early clinical experience.
    Weir E; Paton J
    J Asthma; 2020 May; 57(5):521-524. PubMed ID: 30795693
    [No Abstract]   [Full Text] [Related]  

  • 58. Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.
    Khatri S; Moore W; Gibson PG; Leigh R; Bourdin A; Maspero J; Barros M; Buhl R; Howarth P; Albers FC; Bradford ES; Gilson M; Price RG; Yancey SW; Ortega H
    J Allergy Clin Immunol; 2019 May; 143(5):1742-1751.e7. PubMed ID: 30359681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Churg-Strauss syndrome in a patient with asthma treated with montelukast].
    Rutgers B; Bijl M
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1495; author reply 1495. PubMed ID: 18666669
    [No Abstract]   [Full Text] [Related]  

  • 60. Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys.
    Hart TK; Cook RM; Zia-Amirhosseini P; Minthorn E; Sellers TS; Maleeff BE; Eustis S; Schwartz LW; Tsui P; Appelbaum ER; Martin EC; Bugelski PJ; Herzyk DJ
    J Allergy Clin Immunol; 2001 Aug; 108(2):250-7. PubMed ID: 11496242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.